The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Bukharov A.V.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center

Derzhavin V.A.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center

Yadrina A.V.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center

Erin D.A.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center

Elkhov D.O.

Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center

Surgical treatment in patients with lung cancer bone metastases

Authors:

Bukharov A.V., Derzhavin V.A., Yadrina A.V., Erin D.A., Elkhov D.O.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2022;11(4): 28‑33

Read: 3272 times


To cite this article:

Bukharov AV, Derzhavin VA, Yadrina AV, Erin DA, Elkhov DO. Surgical treatment in patients with lung cancer bone metastases. P.A. Herzen Journal of Oncology. 2022;11(4):28‑33. (In Russ.)
https://doi.org/10.17116/onkolog20221104128

Recommended articles:
Giant peri­cranial sinus with exte­nsive occi­pital calvarium defect. Burdenko's Journal of Neurosurgery. 2024;(6):77-87
Clinical case of auri­cular gouty tophi. Russian Bulletin of Otorhinolaryngology. 2024;(6):80-84
Surgical access for thoracic and intrathoracic goiter. Piro­gov Russian Journal of Surgery. 2025;(1):54-61
En plaque convexity hype­rostotic meni­ngioma: 69 cases from a singlecenter. Burdenko's Journal of Neurosurgery. 2025;(1):20-29

References:

  1. Kaprin AD, Starinskii VV, Shakhzadova AO. The state of oncological care for the population of Russia in 2019. M.: NMITs radiologii Ministerstva zdravookhraneniya Rossiiskoi Federatsii; 2020. (In Russ.).
  2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108.  https://doi.org/10.3322/caac.21262
  3. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115-132.  https://doi.org/10.3322/caac.21338
  4. Sugiura H, Yamada K, Sugiura T, Hida T, Mitsudomi T. Predictors of survival in patients with bone metastasis of lung cancer. Clin Orthop Relat Res. 2008;466(3):729-736.  https://doi.org/10.1007/s11999-007-0051-0
  5. Wang Z, Ning L, Li H, Yang Y, Wu CG, Zhao H, Yao Y. Clinical observation of percutaneous osteoplasty in the treatment of 92 lung cancer patients with extraspinal bone metastases. Tumor. 2014;34(5):443-449. 
  6. Bukharov AV, Derzhavin VA, Erina DA, Yadrina AV, Aliev MD. Surgical treatment of metastatic lesions of the pelvic bones. Journal of Modern Oncology= Sovremennaya onkologiya. 2020;22(4):72-76. (In Russ.). https://doi.org/10.26442/18151434.2020.4.200256
  7. LeVasseur N, Clemons M, Hutton B, Shorr R, Jacobs C. Bone-targeted therapy use in patients with bone metastases from lung cancer: A systematic review of randomized controlled trials. Cancer Treat Rev. 2016;50:183-193.  https://doi.org/10.1016/j.ctrv.2016.09.013
  8. Li Y, Hu C. Prevalence and prognosis of synchronous distant metastatic tonsil squamous cell carcinomas. Int J Med Sci. 2021;18(2):528-533.  https://doi.org/10.7150/ijms.50966
  9. Guerrieri AN, Montesi M, Sprio S, Laranga R, Mercatali L, Tampieri A, Donati DM, Lucarelli E. Innovative options for bone metastasis treatment: an extensive analysis on biomaterials-based strategies for orthopedic surgeons. Front Bioeng Biotechnol. 2020;8:589964. https://doi.org/10.3389/fbioe.2020.589964
  10. Mertsoylu H, Köse F, Sümbül AT, Sedef AM, Doğan Ö, Besen AA, Parlak C, Fındıkçıoğlu A, Muallaoğlu S, Sezer A, et al. Concurrent chemoradiotherapy with vinorelbine plus split-dose cisplatin may be an option in inoperable stage III non-small cell lung cancer: a single-center experience. Med Sci Monit. 2015;21:661-666.  https://doi.org/10.12659/MSM.892730
  11. Zhang L, Hou G, Gao M, Zheng Y, Dun X, Hou N, Zheng W, Yan F, Lu J, Meng P, Ju D, Yuan J, Wei D, Zhu Z, Wang F, Yuan J. Novel survival nomograms for patients with lung metastatic clear cell renal cell carcinoma: a population-based study. Medicine (Baltimore). 2020;99(52):e23465. https://doi.org/10.1097/MD.0000000000023465
  12. Owari T, Miyake M, Nakai Y, Tanaka N, Itami Y, Hirao S, Momose H, Nakagawa Y, Iida K, Maesaka F, et al. External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): comparison with other scoring models in terms of accuracy. J Bone Oncol. 2020;26:100344. https://doi.org/10.1016/j.jbo.2020.100344
  13. Kadota K, Sima CS, Arcila ME, Hedvat C, Kris MG, Jones DR, Adusumilli PS, Travis WD. KRAS mutation is a significant prognostic factor in early-stage lung adenocarcinoma. Am J Surg Pathol. 2016;40(12):1579-1590. https://doi.org/10.1097/PAS.0000000000000744
  14. Wei LY, Kok SH, Lee YC, Chiu WY, Wang JJ, Cheng SJ, Chang HH, Lee JJ. Prognosis of medication-related osteonecrosis of the jaws in metastatic prostate cancer patients. Oral Dis. 2022;28(1):182-192.  https://doi.org/10.1111/odi.13737
  15. Wang CY, Zhang XY. (99m)Tc-MDP wholebody bone imaging in evaluation of the characteristics of bone metastasis of primary lung cancer. Zhonghua Zhong Liu Za Zhi. 2010;32(5):382-386. 
  16. Bauer HC. Controversies in the surgical management of skeletal metastases. J Bone Joint Surg Br. 2005;87(5):608-617.  https://doi.org/10.1302/0301-620X.87B5.16021
  17. Bollen L, van der Linden YM, Pondaag W, Fiocco M, Pattynama BP, Marijnen CA, Nelissen RG, Peul WC, Dijkstra PD. Prognostic factors associated with survival in patients with symptomatic spinal bone metastases: a retrospective cohort study of 1,043 patients. Neuro Oncol 2014;16(7):991-998.  https://doi.org/10.1093/neuonc/not318
  18. Nishiyama N, Taguchi K, Yokoyama T, Ichinose Y, Kage M. Morphometric and cytomorphologic characterization of EGFR-mutated cancer cells-comparison between cultured lung cancer cell lines and lung adenocarcinoma clinical samples. Diagn Cytopathol. 2016;44(9):717-724.  https://doi.org/10.1002/dc.23514
  19. Bukharov AV, Aliev MD, Derzhavin VA, Yadrina AV. Strategy for personalized surgical treatment of cancer patients with bone metastases. P.A. Herzen Journal of Oncology. 2020;9(3):61-65 (In Russ.). https://doi.org/10.17116/onkolog2020903161
  20. Kaprin AD, Aliev MD, Bukharov AV, Larionov DA, Babaev EV, Derzhavin VA, Yadrina AV, Erin DA. Software for the development of tactics of surgical treatment in metastatic bone lesions. Certificate of registration of the computer program No. 2021614241. 03/22/2021 Application No. 2021614241 dated 03/22/2021. (In Russ.).
  21. Janssen SJ, van der Heijden AS, van Dijke M, Ready JE, Raskin KA, Ferrone ML, Hornicek FJ, Schwab JH. 2015 Marshall Urist Young Investigator Award: prognostication in patients with long bone metastases: does a boosting algorithm improve survival estimates? Clin Orthop Relat Res. 2015;473(10):3112-3121. https://doi.org/10.1007/s11999-015-4446-z
  22. Katagiri H, Okada R, Takagi T, Takahashi M, Murata H, Harada H, Nishimura T, Asakura H, Ogawa H. New prognostic factors and scoring system for patients with skeletal metastasis. Cancer Med. 2014;3(5):1359-1367. https://doi.org/10.1002/cam4.292

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.